Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-05-20
2008-05-20
Landsman, Robert S. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
10500175
ABSTRACT:
The present invention intends to provide a body weight gain inhibitor and the like. The ligand of the present invention is useful as a superior body weight gain inhibitor and the like, or for a screening of the superior body weight gain inhibitor and the like.
REFERENCES:
patent: 7193033 (2007-03-01), Mori et al.
patent: 1 293 567 (2003-03-01), None
patent: 1 344 823 (2003-09-01), None
patent: 1 403 281 (2004-03-01), None
patent: 09-121865 (1997-05-01), None
patent: WO 95/12670 (1995-05-01), None
patent: WO-03/082907 (2003-10-01), None
Rohner-Jearnrenaud et al., The New Eng. J. Med., 334: 324-325, 1996.
Campfield et al., Science 280: 1383-1387, 1998.
Grasso et al., Endocrinol. 138: 1413-1418, 1997.
Mickle et al., Med. Clin. North Am., 2000, vol. 84(3), p. 597-607.
Adelhorst et al., J. Biol. Chem. 269: 6275-6278, 1994.
O'Dowd et al., “The Cloning and Chromosomal Mapping of Two Novel Human Opioid-Somatostatin-like Receptor Genes, GPR7 and GPR8, Expressed in Discrete Areas of the Brain,”Genomics28:84-91 (1995).
Hirokazu Matsumoto
Jiro Noguchi
Masaaki Mori
Mioko Harada
Chandra Gyan
Conlin David G.
Edwards Angell Palmer and Dodge LLP
Kim Dwight D.
Landsman Robert S.
LandOfFree
Body weight gain inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Body weight gain inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Body weight gain inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3903659